SFV HEALTHCARE
Recent and archived news stories on: Biotechnology, Doctors, Drugs, Health Insurance, HMO's/PPO's, Hospitals, Medical Devices, Nursing...
Amgen, Allergan Launch Cancer Biosimilars in U.S. Market
Thousand Oaks-based Amgen Inc. and Allergan plc, headquartered in Dublin, Ireland, on Friday announced two biosimilar drugs for cancer treatment which the companies co-developed are now for sale in the United States.
Firms Partner to Develop Thousand Oaks Senior Living Facility
Canyon Partners Real Estate LLC has provided $10.9 million of preferred equity to Griffin Living to finance the construction of an 86-unit senior living facility in Thousand Oaks.
Simulations Plus to Test Veterinary Medicines for FDA
Simulations Plus Inc. has entered into a five-year research collaboration agreement with the U.S. Food and Drug Administration’s Center for Veterinary Medicine to test drug efficacy in animals.
MannKind Partners with GoodRx App
MannKind Corp. in Westlake Village has partnered with Santa Monica’s GoodRx, an app that allows people to see the best prices for drugs.
Canoga Park Senior Facility Cuts Ribbon
Canyon Trails Senior Living and Memory Care hosted a ribbon-cutting ceremony to celebrate its recent membership with the West Valley-Warner Center Chamber of Commerce and completion of a major renovation.
Amgen Alzheimer Program Scrapped
A collaborative research program with Alzheimer’s patients involving Thousand Oaks-based Amgen Inc., Swiss drug maker Novartis and Banner Alzheimer’s Institute in Arizona is discontinued.
Advanced Bionics Launches Cochlear Implant Monitor
Valencia’s Advanced Bionics unveiled its latest product, the AIM system, at a cochlear implant symposium in Florida.
Court Sides With Amgen, Drug Makers to Block TV Ad Rule
U.S. District Judge Amit Mehta has blocked temporarily a Trump administration rule requiring drug makers to put a drug’s list price in television ads pending resolution of a lawsuit on the policy.
Oakmont Stages Preview of Valencia Facility
Oakmont Senior Living held an open house at its new Valencia location on Friday to introduce care options to prospective customers in preparation for an official opening on July 13.
Negative Opinion Issued on Amgen Drug
The European Medicines Agency issued a negative opinion for Amgen Inc.’s Evenity, a drug to treat osteoporosis, according to a statement issued by the company on Friday.
Two Biotechs Win Amgen Golden Tickets
Amgen Inc., with the help of San Francisco-based MBC BioLabs, has awarded the Amgen Golden Ticket to two biotherapeutic companies.
Amgen Partners With Washington University for Cancer Research
Amgen Inc. and the University of Washington’s Institute for Protein Design have announced a partnership to develop protein-building research projects for new medicines.
Endonovo Recruits Johns Hopkins Professor to Advisory Board
Endonovo Therapeutics, an electric therapy device maker, has named Dr. Steven Levin to its scientific.
Venture Capital Firm Keynotes Bioscience Alliance Event
The Conejo Valley’s BioScience Alliance hosted Westlake Village BioPartners, a quickly growing venture capital firm, for its meeting Thursday night.
Casamba Adds Compliance Software Business to Partner List
Casamba, an electronic medical record provider, has added HIPAA One to its partner network, according to a statement from the company on Thursday.
Prev Next